المؤلفون: Jie Xu, Jin Gu, Yuan Li, Lu Xie, Tingting Ren, Danhua Shen, Yi Huang, Rongli Yang, Wei Guo, Kuisheng Liu, Xiaodong Tang, Xin Sun, Bingxin Zheng, Kunkun Sun, Taiqiang Yan

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Male, Oncology, Cancer Research, Pyridines, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Administration, Oral, clinical trials, phase II as topic, chemistry.chemical_compound, biomarkers, tumor, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Immunology and Allergy, Medicine, Apatinib, Child, Infusions, Intravenous, Anti pd1, Immune Checkpoint Inhibitors, RC254-282, Clinical/Translational Cancer Immunotherapy, Osteosarcoma, drug therapy, combination, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Progression-Free Survival, immunohistochemistry, Toxicity, Disease Progression, Molecular Medicine, Female, Open label, Adult, medicine.medical_specialty, pediatrics, Adolescent, Immunology, Bone Neoplasms, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, Young Adult, Internal medicine, Humans, Protein Kinase Inhibitors, Pharmacology, Chemotherapy, business.industry, Correction, medicine.disease, Discontinuation, chemistry, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ffba5f6fb58e230315439811ae2c303Test
https://doi.org/10.1136/jitc-2020-000798Test

المؤلفون: Young Sik Kim, Ju Han Lee, Hong Seok Park, Jung Woo Choi

المصدر: Journal of Clinical Pathology. 64:893-897

مصطلحات موضوعية: Adult, Male, Time Factors, Kaplan-Meier Estimate, Biology, Polymerase Chain Reaction, Risk Assessment, Disease-Free Survival, Pathology and Forensic Medicine, law.invention, chemistry.chemical_compound, Gene Frequency, Downregulation and upregulation, Risk Factors, law, Polymorphism (computer science), Plasminogen Activator Inhibitor 1, Republic of Korea, Biomarkers, Tumor, medicine, Humans, Promoter Regions, Genetic, Carcinoma, Renal Cell, Survival rate, Polymerase chain reaction, Aged, Neoplasm Staging, Proportional Hazards Models, Chi-Square Distribution, Polymorphism, Genetic, Age Factors, Sequence Analysis, DNA, General Medicine, Middle Aged, Prognosis, medicine.disease, Immunohistochemistry, Molecular biology, Kidney Neoplasms, Up-Regulation, Survival Rate, Clear cell renal cell carcinoma, chemistry, Plasminogen activator inhibitor-1, Female, Plasminogen activator

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fd51df84fc1c1d7202ccddae2f599aeTest
https://doi.org/10.1136/jclinpath-2011-200182Test